In MT/Ret mice, the inhibition of myeloid cells and the stimulation of cytotoxic cells driven by propranolol are not sufficient to eradicate metastases but we cannot exclude that the constitutive expression of the oncogene ret, a neurotrophin receptor, artificially supports tumor progression and immune evasion. The gene discussed is RET; the disease is neoplasm.